NorthStar Medical Radioisotopes has received two custom-built IBA Rhodotron TT 300-HE electron beam accelerators at its facility, the company announced recently.

According to a release, the accelerators are critical components in a first-of-its-kind commercial-scale process to produce Mo-99.

“Delivery of these electron beam accelerators to advance Mo-99 production marks a tremendous milestone event for NorthStar, nuclear medicine and the patients who rely on diagnostic imaging studies for their health,” NorthStar Medical Radioisotopes CEO Stephen Merrick said in a statement.

The medical imaging radioisotope informs healthcare decisions for approximately 40,000 patients in the United States daily.